Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(10-Feb-25 10:39) NATCO Pharma gets final approval for its ANDA for Bosentan tablets
(10-Feb-25 09:16) Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
(06-Feb-25 13:06) Natco Pharma Ltd soars 3.15%, up for third straight session
(31-Jan-25 10:24) Natco Pharma to hold board meeting
(30-Jan-25 12:57) NATCO Pharma gets approval for its ANDA for Everolimus tablets
(30-Jan-25 09:43) Natco Pharma receives approval for its ANDA for Everolimus tablets for oral suspension
(19-Dec-24 13:05) Natco Pharma Ltd gains for third straight session
(03-Dec-24 13:06) Natco Pharma Ltd soars 1.05%, Gains for third straight session
(28-Nov-24 11:31) Natco Pharma sells Telangana land for Rs 116 crore
(21-Nov-24 17:35) Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution

1 2 3 4 5 6 7 8 9 10

Natco Pharma Ltd